SEC Form 4/A · accession 0001144204-18-045988
FENNEC PHARMACEUTICALS INC. · FENC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Rosty Raykov
Officer — Chief Executive Officer · Director
Period of report
Aug 20, 2018
Accepted (ET)
Aug 22, 2018 · 7:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001211583
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 20, 2018 | M | 17,050 | $1.44 | A | 57,790 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The original Form 4 filed on August 21, 2018 is amended by this Form 4 amendment to correctly reflect the reporting person's ownership of Common Stock and to reflect reporting person is a Director. No other changes have been made to the original Form 4.